EXOSC3

exosome component 3, the group of Exosome complex

Basic information

Region (hg38): 9:37759234-37832117

Links

ENSG00000107371NCBI:51010OMIM:606489HGNC:17944Uniprot:Q9NQT5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • pontocerebellar hypoplasia type 1A (Definitive), mode of inheritance: AR
  • pontocerebellar hypoplasia type 1B (Strong), mode of inheritance: AR
  • pontocerebellar hypoplasia type 1B (Strong), mode of inheritance: AR
  • pontocerebellar hypoplasia type 1 (Supportive), mode of inheritance: AR
  • pontocerebellar hypoplasia type 1B (Definitive), mode of inheritance: AR
  • pontocerebellar hypoplasia type 1B (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Pontocerebellar hypoplasia type 1BARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic11020648; 12731647; 22544365; 24524299; 25149867

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the EXOSC3 gene.

  • Pontocerebellar hypoplasia type 1B (20 variants)
  • not provided (2 variants)
  • Abnormality of the nervous system (1 variants)
  • Hypotonia (1 variants)
  • Pontoneocerebellar hypoplasia (1 variants)
  • Inborn genetic diseases (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the EXOSC3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
81
clinvar
4
clinvar
85
missense
1
clinvar
7
clinvar
62
clinvar
2
clinvar
1
clinvar
73
nonsense
2
clinvar
3
clinvar
5
start loss
4
clinvar
2
clinvar
6
frameshift
13
clinvar
3
clinvar
2
clinvar
18
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
1
6
7
non coding
36
clinvar
22
clinvar
9
clinvar
67
Total 20 17 103 105 14

Highest pathogenic variant AF is 0.000480

Variants in EXOSC3

This is a list of pathogenic ClinVar variants found in the EXOSC3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-37761968-G-A not specified Uncertain significance (Apr 04, 2023)2532867
9-37761975-C-T not specified Uncertain significance (May 23, 2023)2550167
9-37762069-G-C not specified Uncertain significance (Aug 30, 2021)2353074
9-37762586-C-G not specified Uncertain significance (Jul 05, 2022)2407980
9-37762614-T-C not specified Uncertain significance (Feb 15, 2023)2464472
9-37762634-A-G not specified Uncertain significance (Jun 22, 2021)2234491
9-37762667-A-C not specified Uncertain significance (Aug 17, 2021)2370683
9-37763635-G-A not specified Uncertain significance (May 16, 2023)2511605
9-37763715-T-C not specified Uncertain significance (Feb 27, 2023)2489842
9-37769942-T-C not specified Uncertain significance (Apr 26, 2023)2541173
9-37769958-A-C not specified Uncertain significance (May 26, 2024)3329060
9-37769999-T-C not specified Uncertain significance (May 09, 2022)2288193
9-37770710-G-A not specified Uncertain significance (Aug 22, 2023)2620670
9-37770723-A-T not specified Uncertain significance (Feb 22, 2023)2487004
9-37770724-T-G not specified Uncertain significance (Feb 22, 2023)2487005
9-37776285-G-T not specified Uncertain significance (May 26, 2024)3329062
9-37776303-C-T not specified Likely benign (Mar 19, 2024)3329061
9-37776373-A-C not specified Uncertain significance (Nov 14, 2023)3182990
9-37777616-C-G not specified Uncertain significance (Jan 23, 2024)3182991
9-37777622-A-T Likely benign (Jan 01, 2023)801361
9-37777623-C-A Likely benign (Jan 01, 2023)801362
9-37777666-T-C not specified Uncertain significance (Jan 10, 2022)2271168
9-37777687-C-T not specified Uncertain significance (Nov 03, 2023)3182992
9-37777691-G-A not specified Likely benign (Feb 06, 2023)2471012
9-37779725-C-T Pontocerebellar hypoplasia type 1B Uncertain significance (Jan 13, 2018)366867

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
EXOSC3protein_codingprotein_codingENST00000327304 434460
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0002430.7771256950531257480.000211
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2241621541.050.000006851745
Missense in Polyphen5956.3031.0479681
Synonymous-2.848759.21.470.00000273575
Loss of Function1.08710.80.6465.54e-7131

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007100.000681
Ashkenazi Jewish0.000.00
East Asian0.0009280.000925
Finnish0.000.00
European (Non-Finnish)0.0001120.000105
Middle Eastern0.0009280.000925
South Asian0.0001320.000131
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC3 as peripheral part of the Exo-9 complex stabilizes the hexameric ring of RNase PH-domain subunits through contacts with EXOSC9 and EXOSC5. {ECO:0000269|PubMed:11782436, ECO:0000269|PubMed:17545563, ECO:0000269|PubMed:19056938, ECO:0000269|PubMed:21255825}.;
Disease
DISEASE: Pontocerebellar hypoplasia 1B (PCH1B) [MIM:614678]: A severe autosomal recessive neurologic disorder characterized by a combination of cerebellar and spinal motor neuron degeneration beginning at birth. There is diffuse muscle weakness, progressive microcephaly, global developmental delay, and brainstem involvement. {ECO:0000269|PubMed:22544365}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
RNA degradation - Homo sapiens (human);Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;KSRP (KHSRP) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;mRNA decay by 3, to 5, exoribonuclease;Deadenylation-dependent mRNA decay (Consensus)

Recessive Scores

pRec
0.109

Intolerance Scores

loftool
0.320
rvis_EVS
0.62
rvis_percentile_EVS
83.25

Haploinsufficiency Scores

pHI
0.0805
hipred
Y
hipred_score
0.748
ghis
0.575

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.924

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Exosc3
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
exosc3
Affected structure
motor neuron
Phenotype tag
abnormal
Phenotype quality
branchiness

Gene ontology

Biological process
exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing;nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';U4 snRNA 3'-end processing;regulation of mRNA stability;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;DNA deamination;isotype switching;positive regulation of isotype switching;CUT catabolic process;nuclear polyadenylation-dependent rRNA catabolic process;nuclear polyadenylation-dependent tRNA catabolic process;nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription;polyadenylation-dependent snoRNA 3'-end processing
Cellular component
nuclear exosome (RNase complex);cytoplasmic exosome (RNase complex);exosome (RNase complex);nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol;transcriptionally active chromatin
Molecular function
3'-5'-exoribonuclease activity;RNA binding;exoribonuclease activity;protein binding